Last Updated: 06/18/2024
This policy explains the rights of California residents regarding the collection, use, sale, and sharing of their personal information under the California Consumer Privacy Act of 2018 (CCPA), as amended by the California Privacy Rights Act of 2020 (CPRA). We may update and make changes to this policy, so we encourage you to review it periodically. This policy does not cover Protected Health Information (“PHI”) as such term is defined under Health Insurance Portability and Accountability Act of 1996, as amended from time to time. For information relating to how we handle your PHI, please see our Notice of Privacy Practice.
We, us, our | iMDx, Inc |
Personal information | Any information that identifies, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked with a particular consumer or household. |
Sensitive personal information | Personal information revealing a consumer’s social security number, driver’s license and passport numbers, account numbers and credentials, precise geolocation, racial or ethnic origin, religious beliefs, or union membership, personal information concerning a consumer’s health, sex life, or sexual orientation, contents of a consumer’s mail, email and text messages where the business is not the intended recipient, genetic data, biometric information, and citizenship or immigration status. |
Biometric Information | An individual’s physiological, biological, or behavioral characteristics, including information pertaining to an individual’s deoxyribonucleic acid (DNA), that is used or is intended to be used singly or in combination with each other or with other identifying data, to establish individual identity. Biometric information includes, but is not limited to, imagery of the iris, retina, fingerprint, face, hand, palm, vein patterns, and voice recordings, from which an identifier template, such as a faceprint, a minutiae template, or a voiceprint, can be extracted, and keystroke patterns or rhythms, gait patterns or rhythms, and sleep, health, or exercise data that contain identifying information. |
Categories of Personal Information | Specific Types of Personal Information Collected |
Identifiers (e.g., a real name, alias, postal address, unique personal identifier, online identifier, Internet Protocol address, email address, account name, social security number, driver’s license number, passport number, or other similar identifiers) | Real name, username, IP addresses, and email. |
Information that identifies, relates to, describes, or is capable of being associated with, a particular individual, including, but not limited to, his or her name, signature, social security number, physical characteristics or description, address, telephone number, passport number, driver’s license or state identification card number, insurance policy number, education, employment, employment history, bank account number, credit card number, debit card number, or any other financial information, medical information, or health insurance information. | Name, address, telephone number, education, employment, employment history, credit card or debit card number, and payment information. |
Characteristics of protected classifications under California or federal law | None. |
Commercial information (e.g., records of personal property, products or services purchased, obtained, or considered, or other purchasing or consuming histories or tendencies) | Product or services purchased; purchasing history. |
Biometric information | None. |
Internet or other electronic network activity information (e.g., browsing history, search history, and information regarding a consumer’s interaction with an Internet Web site, application, or advertisement) | Site collects data via Google Analytics. |
Geolocation data | None. |
Audio, electronic, visual, thermal, olfactory, or similar information | None. |
Professional or employment-related information | Employment Information for job applicants who have submitted such information. |
Education information, defined as information that is not publicly available personally identifiable information as defined in the Family Educational Rights and Privacy Act (FERPA) | Education Information for job applicants who have submitted such information. |
Inferences drawn from any of the information identified above to create a profile about a consumer reflecting the consumer’s preferences, characteristics, psychological trends, predispositions, behavior, attitudes, intelligence, abilities, and aptitudes | None. |
Sensitive Personal Information | None. |
A legitimate interest is when we have a business or commercial reason to use your information, so long as this is not overridden by your own rights and interests.
The table below explains what we use (process) your personal information for and our reasons for doing so:
What we use your personal information for | Our reasons |
To provide products and/or services to you | For the performance of our contract with you or to take steps at your request before entering into a contract |
To prevent and detect fraud against you or us. | For our legitimate interests or those of a third party, i.e., to minimize fraud that could be damaging for us and for you |
Conducting checks to identify our customers and verify their identity Screening for financial and other sanctions or embargoes Other processing necessary to comply with professional, legal and regulatory obligations that apply to our business, e.g., under health and safety regulation or rules issued by our professional regulator | To comply with our legal and regulatory obligations |
Gathering and providing information required by or relating to audits, enquiries or investigations by regulatory bodies | To comply with our legal and regulatory obligations |
Ensuring business policies are adhered to, e.g., policies covering security and internet use | For our legitimate interests or those of a third party, i.e., to make sure we are following our own internal procedures so we can deliver the best service to you |
Operational reasons, such as improving efficiency, training and quality control | For our legitimate interests or those of a third party, i.e., to be as efficient as we can so we can deliver the best service for you at the best price |
Ensuring the confidentiality of commercially sensitive information | For our legitimate interests or those of a third party, i.e., to protect trade secrets and other commercially valuable information To comply with our legal and regulatory obligations |
Statistical analysis to help us manage our business, e.g., in relation to our financial performance, customer base, product range or other efficiency measures | For our legitimate interests or those of a third party, i.e., to be as efficient as we can so we can deliver the best service for you at the best price |
Preventing unauthorized access and modifications to systems | For our legitimate interests or those of a third party, i.e., to prevent and detect criminal activity that could be damaging for us and for you To comply with our legal and regulatory obligations |
Updating and enhancing customer records | For the performance of our contract with you or to take steps at your request before entering into a contract To comply with our legal and regulatory obligations For our legitimate interests or those of a third party, e.g., making sure that we can keep in touch with our customers about existing orders and new products |
Statutory returns | To comply with our legal and regulatory obligations |
Ensuring safe working practices, staff administration and assessments | To comply with our legal and regulatory obligations For our legitimate interests or those of a third party, e.g., to make sure we are following our own internal procedures and working efficiently so we can deliver the best service to you |
Marketing our services [and those of selected third parties] to: —existing and former customers; —third parties who have previously expressed an interest in our services; —third parties with whom we have had no previous dealings. | For our legitimate interests or those of a third party, i.e., to promote our business to existing and former customers |
Credit reference checks via external credit reference agencies | For our legitimate interests or those of a third party, i.e., to ensure our customers are likely to be able to pay for our products and services |
External audits and quality checks, e.g., for accreditations and the audit of our accounts | For our legitimate interests or a those of a third party, i.e., to maintain our accreditations so we can demonstrate we operate at the highest standards To comply with our legal and regulatory obligations |
We only allow our service providers to handle your personal information if we are satisfied, they take appropriate measures to protect your personal information. We also impose contractual obligations on service providers, contractors, and third parties to ensure they can only use your personal information to provide services to us and to you.
We may disclose and exchange information with law enforcement agencies and regulatory bodies to comply with our legal and regulatory obligations.
We may also need to share some personal information with other parties, such as potential buyers of some or all of our business or during a re-structuring. We will typically anonymize information, but this may not always be possible. The recipient of the information will be bound by confidentiality obligations.
We will not retain your personal information for longer than necessary for the purposes set out in this policy. Different retention periods apply for different types of personal information.
Disclosure of Personal Information We Collect About You | You have the right to know, and request disclosure of: • The categories of personal information we have collected about you, including sensitive personal information; • The categories of sources from which the personal information is collected; • Our business or commercial purpose for collecting, selling, or sharing personal information; • The categories of third parties to whom we disclose personal information, if any; and • The specific pieces of personal information we have collected about you. Please note that we are not required to: • Retain any personal information about you that was collected for a single one-time transaction if, in the ordinary course of business, that information about you is not retained; • Reidentify or otherwise link any data that, in the ordinary course of business, is not maintained in a manner that would be considered personal information; or • Provide the personal information to you more than twice in a 12-month period. |
Disclosure of Personal Information Sold, Shared, or Disclosed for a Business Purpose | In connection with any personal information we may sell, share, or disclose to a third party for a business purpose, you have the right to know: • The categories of personal information about you that we sold or shared and the categories of third parties to whom the personal information was sold or shared; and • The categories of personal information that we disclosed about you for a business purpose and the categories of persons to whom the personal information was disclosed for a business purpose. You have the right to opt-out of the sale of your personal information or sharing of your personal information for the purpose of targeted behavioral advertising. If you exercise your right to opt-out of the sale or sharing of your personal information, we will refrain from selling or sharing your personal information, unless you subsequently provide express authorization for the sale or sharing of your personal information. To opt-out of the sale or sharing of your personal information, visit our homepage and click on the Do Not Sell or Share My Personal Information link here: imdxinc.com. |
Right to Limit Use of Sensitive Personal Information | You have the right to limit the use and disclosure of your sensitive personal information to the use which is necessary to: Perform the services or provide the goods reasonably expected by an average consumer who requests those goods or services; To perform the following services: (1) Helping to ensure security and integrity to the extent the use of the consumer’s personal information is reasonably necessary and proportionate for these purposes; (2) Short-term, transient use, including, but not limited to, non-personalized advertising shown as part of a consumer’s current interaction with the business, provided that the consumer’s personal information is not disclosed to another third party and is not used to build a profile about the consumer or otherwise alter the consumer’s experience outside the current interaction with the business; (3) Performing services on behalf of the business, including maintaining or servicing accounts, providing customer service, processing or fulfilling orders and transactions, verifying customer information, processing payments, providing financing, providing analytic services, providing storage, or providing similar services on behalf of the business; and (4) Undertaking activities to verify or maintain the quality or safety of a service or device that is owned, manufactured, manufactured for, or controlled by the business, and to improve, upgrade, or enhance the service or device that is owned, manufactured, manufactured for, or controlled by the business; and As authorized by further regulations You have a right to know if your sensitive personal information may be used, or disclosed to a service provider or contractor, for additional, specified purposes. To limit the use of your sensitive personal information, visit our homepage and click on the “Limit the Use of My Sensitive Personal Information” link here: https://imdxinc.com/ |
Right to Deletion | Subject to certain exceptions set out below, on receipt of a verifiable request from you, we will: • Delete your personal information from our records; and • Direct any service providers or contractors to delete your personal information from their records. • Direct third parties to whom the business has sold or shared your personal information to delete your personal information unless this proves impossible or involves disproportionate effort. Please note that we may not delete your personal information if it is reasonably necessary to: • Complete the transaction for which the personal information was collected, fulfill the terms of a written warranty or product recall conducted in accordance with federal law, provide a good or service requested by you, or reasonably anticipated within the context of our ongoing business relationship with you, or otherwise perform a contract between you and us; • Help to ensure security and integrity to the extent the use of the consumer’s personal information is reasonably necessary and proportionate for those purposes; • Debug to identify and repair errors that impair existing intended functionality; • Exercise free speech, ensure the right of another consumer to exercise his or her right of free speech, or exercise another right provided for by law; • Comply with the California Electronic Communications Privacy Act; • Engage in public or peer-reviewed scientific, historical, or statistical research in the public interest that adheres to all other applicable ethics and privacy laws, when our deletion of the information is likely to render impossible or seriously impair the achievement of such research, provided we have obtained your informed consent; • Enable solely internal uses that are reasonably aligned with your expectations based on your relationship with us • Comply with an existing legal obligation; or • Otherwise use your personal information, internally, in a lawful manner that is compatible with the context in which you provided the information. |
Right of Correction | If we maintain inaccurate personal information about you, you have the right to request us to correct that inaccurate personal information. Upon receipt of a verifiable request from you, we will use commercially reasonable efforts to correct the inaccurate personal information. |
Protection Against Retaliation | You have the right to not be retaliated against by us because you exercised any of your rights under the CCPA/CPRA. This means we cannot, among other things: • Deny goods or services to you; • Charge different prices or rates for goods or services, including through the use of discounts or other benefits or imposing penalties; • Provide a different level or quality of goods or services to you; or • Suggest that you will receive a different price or rate for goods or services or a different level or quality of goods or services. Please note that we may charge a different price or rate or provide a different level or quality of [goods and/or services] to you, if that difference is reasonably related to the value provided to our business by your personal information. We may also offer loyalty, rewards, premium features, discounts, or club card programs consistent with these rights or payments as compensation, for the collection of personal information, the sale of personal information, or the retention of personal information. |
Please note that you may only make a CCPA/CPRA-related data access or data portability disclosure request twice within a 12-month period.
If you choose to contact us directly, you will need to provide us with:
We are not obligated to make a data access or data portability disclosure if we cannot verify that the person making the request is the person about whom we collected information, or is someone authorized to act on such person’s behalf.
Any personal information we collect from you to verify your identity in connection with you request will be used solely for the purposes of verification.
©2025 Insight Molecular Diagnostics Inc. All rights reserved. iMDx, GraftAssureCore, GraftAssureIQ, GraftAssureDx, DetermaIO, DetermaCNI, and OncoTIME are trademarks of Insight Molecular Diagnostics Inc. All other trademarks are the property of their respective owners. For the intended uses of all products, please refer to www.imdxinc.com.
WEBSITE BY: LEFT HAND DESIGN
James Liu joined iMDx in July 2021 and was appointed Vice President of Accounting, Controller, Treasurer, and Principal Accounting Officer in March 2025. He has held several key roles at iMDx, including Senior Director, Controller & Principal Accounting Officer and Manager of SEC Reporting & Compliance. James also served as interim Principal Financial Officer from August 2023 to June 2024, overseeing financial operations and public company reporting.
Before iMDx, James served as Accounting Manager at Acacia Research Corporation, where he led the SEC reporting and compliance, accounting close, and all other financial reporting requirements of an opportunistic capital platform that identifies and acquires other. He also worked as Senior Accountant at Gatekeeper Systems, Inc. and as Senior Assurance Associate at BDO USA, LLP, gaining deep expertise in financial reporting and assurance practices across multiple industries.
James holds a BASc degree from the University of California, San Diego, and is a Certified Public Accountant.
Peter Hong oversees iMDx’s legal department. Before joining iMDx in August 2021, Peter was an associate at Stradling Yocca Carlson & Rauth, P.C., where he represented both public and private companies in capital markets, M&A, and corporate governance matters. Prior to that, he worked at the New York office of Covington & Burling LLP, where he represented underwriters in the initial public offerings and follow-on offerings of biotechnology companies. At Covington, Peter also advised overseas clients with regard to restructuring, employment matters and the formation of U.S. subsidiaries.
Peter earned his JD from Columbia Law School and his Bachelor of Science in Business Administration from Washington University in St. Louis. He is admitted to practice law in New York and California.
Ryan Andrews joined iMDx in 2019 and currently serves as Vice President of Commercial, leading the strategic commercialization of iMDx’s innovative products and solutions. Prior to this role, he held key leadership positions within the company, including Director and Senior Director of Marketing, where he played a pivotal role in shaping iMDx’s market strategy and brand presence.
With extensive experience in the diagnostics and life sciences industry, Ryan brings a deep understanding of market dynamics, business development, and commercial execution. His expertise spans product commercialization, strategic partnerships, and market expansion, ensuring iMDx’s solutions reach the healthcare providers and patients who need them most.
Before joining iMDx, Ryan was a Principal at Bethesda Group, LLC, a boutique consulting firm specializing in guiding small and mid-stage diagnostic companies and investment groups through market entry, product launches, and commercialization strategies. He has also held sales, marketing, and operational leadership roles at Thermo Fisher Scientific, Life Technologies, and Cytovance Biologics, where he gained extensive experience in the biotechnology, diagnostics, and life sciences sectors.
Ryan holds an MBA from the University of Mississippi and remains committed to advancing precision diagnostics and improving patient outcomes through innovative commercial strategies.
Sandra is an activator and results-driven leader with expertise in operational leadership, commercialization, and corporate integration. With a strong record of driving transformation across small and mid-sized organizations, Sandra brings a unique ability to align cross-functional teams, streamline operations, and deliver measurable business outcomes.
Sandra joined iMDx in December 2019, and in her current role, she leads business operations in support of product development, working closely with senior leadership to ensure alignment with the company’s long-term strategic goals. She champions scalable processes, fosters continuous improvement, and supports innovation throughout the organization.
Beyond her corporate responsibilities, Sandra serves as Vice President of the Orange County chapter of the Healthcare Businesswomen’s Association (HBA), where she partners with the board to shape the chapter’s vision, drive strategic initiatives, and engage with the Chapter Advisory Board to elevate leadership and inclusion in the healthcare industry.
Sandra is known for driving consensus among teams, focused execution of goals and turning strategy into action.
Sandra earned a Bachelor of Business Administration (B.B.A.) and HR Management Certification from California State University, Fullerton.
Innovation resonates most with me because it challenges us to find new solutions for patients, for science, and for the future of healthcare. It drives continuous improvement and meaningful impact.
But innovation doesn’t happen in a vacuum. It thrives when grounded in integrity, fueled by courage, aligned with putting patients first, with everyone working as One Team.
To me, innovation is the engine, and it is powered by all our values working together.
Andrea James is an expert in guiding financial strategy through multiple phases of growth, raising and stewarding capital, and building relationships with high quality institutional investors. Prior to joining iMDx in 2024, she served in a series of escalating roles at Axon Enterprise, Inc. (Nasdaq: AXON), including Chief Communications Officer and Head of Investor Relations, and Senior Vice President of Strategy. She played a key role in the company’s growth from a $1 billion to a $20 billion market capitalization and established Axon’s corporate strategy function, overseeing capital stewardship, mergers and acquisitions, strategic partnerships, and investments. Her leadership contributed to more than $550 million in equity capital offerings.
Before joining Axon, Andrea assisted Tesla, Inc. (Nasdaq: TSLA) with strategic investor relations, and has also served as Vice President and Senior Research Analyst at Dougherty & Co. (now Colliers Securities), specializing in researching disruptive technologies.
Andrea holds a Bachelor of Science, summa cum laude, in Computer Information Systems from American University. She also earned a Master of Science in Journalism from Northwestern University, graduating with Kappa Tau Alpha honors.
Johnson Chiang is an experienced technology leader with a strong background in molecular diagnostics, focusing on product development, systems integration, and regulatory strategy. Johnson joined iMDx in 2021, having previously served as Chief Technology Officer at Alveo Technologies, an IVD company that specializes in developing cutting-edge molecular diagnostic tests. At iMDx, he continues to leverage his expertise to drive innovation in diagnostic solutions.
Previously, Johnson led the development of the be.well COVID-19 Test at Alveo Technologies, which completed a U.S. clinical trial and earned the CE mark and UK approval. In addition to his leadership in product development, he was involved in fundraising efforts that raised $50MM over four years and played a key role in securing the XPrize Grand Award for Rapid COVID Testing. Earlier in his career, Johnson was the Head of Systems Integration & Molecular Biology at Foundation Medicine, Inc., and held senior management roles at Life Technologies and Thermo Fisher Scientific. One of his key achievements was leading the Oncomine Dx Target Test, the first NGS-based CDx test approved by the FDA. Additionally, he holds several patents and has published numerous papers in biotechnology.
Johnson holds a Ph.D. in BioMEMS (Micro Electro-Mechanical Systems) from the University of California, Irvine. He also earned a Master of Engineering from The Ohio State University.
Ekkehard (Ekke) Schütz is a renowned leading expert in molecular genetics, diagnostics, and cell-free DNA (cf-DNA) research. He joined iMDx in April 2021 through its acquisition of Chronix Biomedical Inc. and now serves as Managing Director of Chronix Biomedical GmbH (a fully owned subsidiary of iMDx) and Chief Medical Officer (CMO) for Europe.
Under his leadership, Chronix became a leader in cf-DNA diagnostics, producing numerous publications and securing a broad patent portfolio, including ten patent families with many issued patents in the U.S. and Europe, which he invented.
Fellow of the National Academy for Clinical Biochemistry (now FAACC) since 2014, Ekke has published over 190 peer-reviewed papers, contributed to 100+ congress abstracts, and received several international scientific awards. He has also been a reviewer for top scientific journals, including PNAS, Clinical Chemistry, Clinical Biochemistry, and Nucleic Acids Research.
Ekke trained in laboratory medicine at Georg-August-University Hospital in Goettingen, Germany under Prof. Dr. Michael Oellerich, a renowned expert in therapeutic drug monitoring and transplantation surveillance.
Each of our company values is important to me, but the most important one is patient first!
For me as M.D. my major driving force during my entire career was to establish diagnostic measures that would make an impact by helping patients.
It is very satisfying to see that we all at iMDx share this goal as our first corporate value.
Josh Riggs is an accomplished and results-driven business leader with extensive experience in market access, molecular diagnostics, and strategic business development. He joined iMDx in August 2020, where he quickly became a key driver of the company’s growth and innovation. Initially serving as Senior Director of Business Development and General Manager of Transplant, Josh demonstrated exceptional leadership and business acumen, which ultimately led to his appointment as CEO in December 2022. As CEO, Josh has spearheaded the strategic pivot of iMDx, leading the organization to decentralize its testing approach and expand its impact on patient care.
Prior to his tenure at iMDx, Josh founded and led Intelliger Consulting, a firm specializing in healthcare marketing strategies. He also served as a principal at Bethesda Group, LLC, where he advised diagnostic companies and investors on market entry, commercialization, and expansion strategies.
Before venturing into the healthcare and diagnostics sectors, Josh gained valuable operational experience in the manufacturing industry. As part of the team at Industrial Timber, a startup manufacturer, he was responsible for managing and establishing multiple manufacturing facilities across the southeastern United States.
Josh holds an MBA from the University of Mississippi.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.